Literature DB >> 31049265

Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu.

Kimberly R Theos1, Kory M Johnson1, Douglas W Johnson1.   

Abstract

Staphylococcus aureus is a pathogen that causes skin and soft tissue infections (SSTIs) in dermatology patients. There is an increasing rate of methicillin-resistant S aureus (MRSA) reported in the dermatology literature since 1987. This report profiles the antibiotic susceptibilities of methicillin-sensitive S aureus (MSSA) and MRSA in an outpatient office in Hawai'i. This is a retrospective study done by chart review from 2012 to 2014. Demographics, anatomical site of infection, clinical diagnoses and antimicrobial susceptibility patterns were analyzed and compared. Of the 66 samples, 57% were males and 43% were females. S aureus was more commonly found in impetigo, folliculitis, furuncles and secondarily infected psoriasis and more commonly located on the extremities. MSSA accounted for 73% (48) of the cases and MRSA accounted for 27% (18) of the cases. The antibiotics most effective against all S aureus cultures for outpatients were linezolid (100%), trimethoprim sulfamethoxazole (95%) and tetracyclines (94%). Linezolid (100%), trimethoprim sulfamethoxazole (100%) were most effective against MRSA isolates. Our S aureus and MRSA antimicrobial susceptibility results are similar to the local Hawai'i outpatient antibiogram collected from a large private laboratory in Hawai'i in 2014 and the current Infectious Disease Society of America guidelines. This study may be helpful in guiding empiric treatment of SSTIs suspected to be caused by S aureus.

Entities:  

Keywords:  Hawai‘i; Staphylococcus aureus; antimicrobial susceptibility; dermatology; methicillin-resistant S aureus; methicillin-sensitive S aureus; outpatient

Mesh:

Substances:

Year:  2019        PMID: 31049265      PMCID: PMC6495025     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  13 in total

1.  Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility.

Authors:  Alex G Ortega-Loayza; Stephanie A Diamantis; Peter Gilligan; Dean S Morrell
Journal:  J Am Acad Dermatol       Date:  2010-02-21       Impact factor: 11.527

2.  Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance.

Authors:  Melissa L Diamantis; Alex G Ortega-Loayza; Dean S Morrell
Journal:  J Am Acad Dermatol       Date:  2011-02       Impact factor: 11.527

Review 3.  Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.

Authors:  Kassandra Loewen; Yoko Schreiber; Mike Kirlew; Natalie Bocking; Len Kelly
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

4.  Evaluation of antibacterial sensitivity testing methods for methicillin-resistant Staphylococcus aureus in a dermatology outpatient population.

Authors:  M E McBride; D Schaefer; A H Rudolph; S Aldama; J E Wolf
Journal:  South Med J       Date:  1989-02       Impact factor: 0.954

Review 5.  Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.

Authors:  Philip R Cohen
Journal:  Int J Dermatol       Date:  2007-01       Impact factor: 2.736

6.  Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

Authors:  James S Lewis; James H Jorgensen
Journal:  Clin Infect Dis       Date:  2004-12-21       Impact factor: 9.079

Review 7.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.

Authors:  Aaron M Bruce; James M Spencer
Journal:  J Drugs Dermatol       Date:  2008-08       Impact factor: 2.114

9.  Susceptibility of Staphylococcus aureus to topical agents in the United States: a sentinel study.

Authors:  Douglas J Biedenbach; Samuel K Bouchillon; Seth A Johnson; Daryl J Hoban; Meredith Hackel
Journal:  Clin Ther       Date:  2014-05-15       Impact factor: 3.393

10.  Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.

Authors:  Fenfang Li; Sarah Y Park; Tracy L Ayers; F DeWolfe Miller; Ralph MacFadden; Michele Nakata; Myra Ching Lee; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  1 in total

1.  Status of Biofilm-Forming Genes among Jordanian Nasal Carriers of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus.

Authors:  Ashraf I Khasawneh; Nisreen Himsawi; Jumana Abu-Raideh; Muna A Salameh; Mohammad Al-Tamimi; Sameer Al Haj Mahmoud; Tareq Saleh
Journal:  Iran Biomed J       Date:  2020-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.